Board Meeting Details

The Board Meeting was held on 28th October 2026, commencing at 08:30 AM IST and concluding discussion on financial results at 09:25 AM IST. The meeting was continuing for other agenda items at the time of filing.

Key Decisions and Approvals

  • Approved Unaudited Standalone and Consolidated Financial Results for quarter and half year ended 30th September 2026
  • Declared interim dividend of ₹19 per equity share of face value ₹1 each for financial year ending 31st March 2027
  • Fixed record date for interim dividend as Thursday, 12th November 2026
  • Fixed dividend payment date as Wednesday, 25th November 2026

Financial Performance Highlights - Consolidated

Quarterly Performance (Q2 FY27)

  • Turnover: ₹18,071 crores
  • Underlying Sales Growth (USG): 15%
  • Underlying Volume Growth (UVG): 7%
  • EBITDA: ₹4,089 crores (8% growth YoY)
  • EBITDA Margin: 22.6% (declined 140 bps YoY)
  • Profit Before Tax before exceptional items: ₹3,812 crores (9% growth YoY)
  • Profit After Tax before exceptional items: ₹2,795 crores (9% growth YoY)
  • Reported Profit After Tax: ₹2,796 crores (flat YoY due to one-off tax gain of ₹273 crores in base period)
  • Earnings Per Share (Basic): ₹11.87

Half-Yearly Performance (H1 FY27)

  • Turnover: ₹35,255 crores
  • USG: 12%
  • UVG: 6%
  • EBITDA Growth: 8%
  • PAT (before exceptional items) Growth: 9%

Segment-wise Performance - Q2 FY27

Home Care

  • Revenue: ₹6,878 crores
  • USG: 22%
  • UVG: Double-digit growth
  • Margin: 16%
  • Key drivers: Fabric Wash and Household Care delivered double-digit growth across brands and formats

Beauty & Wellbeing

  • Revenue: ₹4,319 crores
  • USG: 16%
  • UVG: Double-digit growth
  • Margin: 29%
  • Key drivers: Hair Care accelerated double-digit growth, Skin Care and Colour Cosmetics delivered double-digit volume-led growth

Personal Care

  • Revenue: ₹2,617 crores
  • USG: 9%
  • UVG: Flat
  • Margin: 17%
  • Key drivers: Skin Cleansing delivered double-digit USG, Oral Care reported low-single digit growth

Foods

  • Revenue: ₹3,849 crores
  • USG: 9%
  • UVG: Low-single digit growth
  • Margin: 22%
  • Key drivers: Lifestyle Nutrition accelerated double-digit growth, Packaged Foods delivered double-digit growth

Exceptional Items

Q2 FY26 included exceptional items net credit of ₹2 crores (profit from disposal of surplus assets). Q2 FY25 had exceptional items including restructuring expenses of ₹51 crores and acquisition/disposal costs of ₹3 crores, plus one-off tax gain of ₹273 crores.

Capital Structure

  • Paid-up equity share capital: ₹235 crores (face value ₹1 per share)
  • Number of shares: 235 crore shares

Cash Flow Statement - H1 FY27 (Consolidated)

  • Cash from operating activities: ₹8,022 crores
  • Cash used in investing activities: ₹3,345 crores
  • Cash used in financing activities: ₹5,462 crores
  • Net decrease in cash: ₹785 crores
  • Cash and cash equivalents at period end: ₹1,798 crores

Balance Sheet Position - Consolidated (30th September 2026)

  • Total Assets: ₹82,907 crores
  • Non-current Assets: ₹60,773 crores
  • Current Assets: ₹22,134 crores
  • Total Equity: ₹49,111 crores
  • Non-current Liabilities: ₹14,501 crores
  • Current Liabilities: ₹19,295 crores

Subsidiary Information

The consolidated results include 23 entities, with Unilever Nepal Limited (assets: ₹514 crores, revenue: ₹130 crores) reviewed by other auditors.

Management Commentary

Priya Nair, CEO and Managing Director, commented: "In September quarter, we delivered 15% Underlying Sales Growth, our highest in the last 14 quarters, with Turnover of ₹18,071 crores. Underlying Volume Growth was strong at 7% reflecting sustained momentum driven by our focus on crafting desirable brands and strengthening future-fit Go-to-Market. Indian economy remains resilient, with healthy macro indicators supporting a positive consumption environment."

Mid-term Outlook

  • Demand environment remains resilient with FY27 expected to be better than FY26
  • Commodity inflation expected to continue in short-term
  • Consolidated EBITDA Margin guidance maintained at 22-24%
  • Focus remains on driving competitive, volume-led profit growth

Documents Enclosed

  • Unaudited Standalone and Consolidated Financial Results
  • Limited Review Report of Auditors
  • Press Release
  • Investor Presentation